Overview

A Study in Healthy People to Test How Itraconazole Influences the Amount of BI 3031185 in the Blood

Status:
NOT_YET_RECRUITING
Trial end date:
2025-12-18
Target enrollment:
Participant gender:
Summary
The main objective of this trial is to investigate the effect of multiple oral doses of the strong CYP3A4 inhibitor itraconazole on the pharmacokinetics of a single dose of BI 3031185 following oral administration.
Phase:
PHASE1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Itraconazole